Nevro Corp. (NYSE:NVRO) Q4 2023 Results Conference Call February 21, 2024 5:00 PM ET

Company Participants

Angie McCabe - Vice President Investor Relations and Corporate Communication

Kevin Thornal - President and Chief Executive Officer

Rod MacLeod - Chief Financial Officer

Conference Call Participants

Kallum Titchmarsh - Morgan Stanley

Nathan Treybeck - Wells Fargo

Shagun Singh - RBC Capital

Adam Maeder - Piper Sandler

Joanne Wuensch - Citi

Richard Newitter - Truist

Brandon Vazquez - William Blair

Bill Plovanic - Canaccord Genuity

Anthony Petrone - Mizuho Group

Suraj Kalia - Oppenheimer

Mike Polark - Wolfe Research

Robbie Marcus - JPMorgan

Operator

Good afternoon and welcome to Nevro's Fourth Quarter and Full Year 2023 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]

I would now like to turn the call over to Angie McCabe, Vice President Investor Relations and Corporate Communication for Nevro. Please go ahead.

Angie McCabe

Thank you, Regina. Good afternoon and welcome to Nevro's fourth quarter and full year 2023 earnings conference call. With me today are Kevin Thornal, CEO and President; and Rod MacLeod, our Chief Financial Officer.

Before we get started, please note that our earnings release and the supplemental presentation accompanying this call are available on the Events and Presentation page of the Investors section of our website at nevro.com. Also, this call is being broadcast live over the Internet to all interested parties, and an archived copy of this webcast will be available in the Investors section of our website shortly after the conclusion of this call.

Before we begin, I'd like to remind everyone that comments made on today's call may include forward-looking statements within the meaning of federal securities laws. Results could differ materially from those expressed or implied as a result of certain risks and uncertainties.

Please refer to Nevro's SEC filings, including our Annual Report on Form 10-K for detailed presentations of risks. The forward-looking statements in this call speak only as of today, and the Company undertakes no obligation to update or revise any of these statements. In addition, management will refer to adjusted EBITDA, a non-GAAP measure used to help investors understand Nevro's ongoing business performance.

Adjusted EBITDA excludes interest, taxes, non-cash items such as stock-based compensation, depreciation and amortization, litigation related expenses and credits, changes in the fair market value of warrants and other adjustments such as gain from extinguishment of debt and restructuring charges. Please refer to the financial tables in our earnings press release issued today for reconciliations of GAAP to non-GAAP financial measures.